AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
+4.88%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.82B
AUM Growth
+$1.18M
(+0.03%)
Cap. Flow
-$187M
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
31.93%
Holding
328
New
76
Increased
87
Reduced
63
Closed
72
Top Buys
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$33.5M |
| 2 |
FIVE9
FIVN
|
$33.1M |
| 3 |
Domino's
DPZ
|
$32.9M |
| 4 |
Incyte
INCY
|
$28.6M |
| 5 |
Humana
HUM
|
$23.6M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$91.8M |
| 2 |
Exact Sciences
EXAS
|
$59.2M |
| 3 |
Sanofi
SNY
|
$53M |
| 4 |
Keurig Dr Pepper
KDP
|
$49.6M |
| 5 |
GSK
GSK
|
$39.9M |
Sector Composition
| 1 | Healthcare | 68.01% |
| 2 | Consumer Discretionary | 11.66% |
| 3 | Consumer Staples | 8.76% |
| 4 | Technology | 8.5% |
| 5 | Communication Services | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HYPD
126
Hyperion DeFi, Inc. Common Stock
HYPD
$35M
| $4.41M | 0.07% |
106,679
+30,921
| +41% | +$1.28M |
|
127
Verastem
VSTM
$650M
| $4.08M | 0.07% |
+1,364,000
| New | +$4.08M |
|
128
Spyre Therapeutics
SYRE
$1.03B
| $4M | 0.06% |
136,000
| – | – |
|
129
Rush Street Interactive
RSI
$2.03B
| $3.8M | 0.06% |
+350,000
| New | +$3.8M |
|
130
Lennar Class A
LEN
$35.8B
| $3.76M | 0.06% |
20,696
-8,630
| -29% | -$1.57M |
|
131
Ondas Holdings
ONDS
$1.46B
| $3.66M | 0.06% |
+4,750,000
| New | +$3.66M |
|
132
Citius Pharmaceuticals
CTXR
$19.6M
| $3.64M | 0.06% |
291,040
-115,200
| -28% | -$1.44M |
|
133
4D Molecular Therapeutics
FDMT
$309M
| $3.63M | 0.06% |
+336,000
| New | +$3.63M |
|
134
Enlivex Therapeutics
ENLV
$25.5M
| $3.59M | 0.06% |
2,139,000
+438,429
| +26% | +$737K |
|
|
AXDX
135
DELISTED
Accelerate Diagnostics
AXDX
| $3.59M | 0.06% |
2,101,000
+493,000
| +31% | +$843K |
|
136
Neuropace
NPCE
$318M
| $3.35M | 0.05% |
+480,000
| New | +$3.35M |
|
137
ProMIS Neurosciences
PMN
$22.3M
| $3.34M | 0.05% |
+2,670,000
| New | +$3.34M |
|
138
Murphy USA
MUSA
$7.21B
| $3.25M | 0.05% |
+6,592
| New | +$3.25M |
|
139
Scilex Holding
SCLX
$142M
| $3.25M | 0.05% |
100,286
-241,143
| -71% | -$7.8M |
|
140
Clene
CLNN
$59.4M
| $3.13M | 0.05% |
+682,374
| New | +$3.13M |
|
141
Melco Resorts & Entertainment
MLCO
$3.94B
| $3.12M | 0.05% |
+400,000
| New | +$3.12M |
|
142
Wayfair
W
$10.7B
| $3.09M | 0.05% |
55,000
-38,000
| -41% | -$2.13M |
|
|
AISP
143
Airship AI Holdings
AISP
$138M
| $2.99M | 0.05% |
+1,300,000
| New | +$2.99M |
|
|
TTOO
144
DELISTED
T2 Biosystems, Inc
TTOO
| $2.75M | 0.04% |
1,396,000
-262,000
| -16% | -$516K |
|
145
Aligos Therapeutics
ALGS
$74.7M
| $2.73M | 0.04% |
315,095
+24,839
| +9% | +$215K |
|
146
FibroGen
FGEN
$45.7M
| $2.72M | 0.04% |
272,000
-85,440
| -24% | -$853K |
|
147
5E Advanced Materials
FEAM
$76.1M
| $2.69M | 0.04% |
+216,522
| New | +$2.69M |
|
|
MTVA
148
MetaVia Inc. Common Stock
MTVA
$16.6M
| $2.69M | 0.04% |
848,000
+151,171
| +22% | +$479K |
|
149
P3 Health Partners
PIII
$28.6M
| $2.57M | 0.04% |
133,000
-25,000
| -16% | -$483K |
|
150
Ekso Bionics
EKSO
$10.6M
| $2.51M | 0.04% |
+144,467
| New | +$2.51M |
|